Ever Source Wealth Advisors, LLC Ligand Pharmaceuticals Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 32 shares of LGND stock, worth $3,537. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32
Previous 32
-0.0%
Holding current value
$3,537
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LGND
# of Institutions
255Shares Held
18.1MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$317 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$218 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$112 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$98.1 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$78.2 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.87B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...